Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Cancers|June 10, 2023
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer ProgressionEnea Ferlizza, Donatella Romaniello, Francesco Borrelli, et al.Biomedicines|August 28, 2025
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target TherapyDaria Maria Filippini, Donatella Romaniello, Francesca Carosi, et al.Cell Reports. Medicine|August 9, 2023
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximabIlaria Marrocco, Suvendu Giri, Arturo Simoni-Nieves, et al.Communications Biology|October 14, 2023
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocationMichela Sgarzi, Martina Mazzeschi, Spartaco Santi, et al.Journal of Experimental & Clinical Cancer Research : CR|March 30, 2022
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancerMartina Mazzeschi, Michela Sgarzi, Donatella Romaniello, et al.NPJ Precision Oncology|April 8, 2026
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapyFederica Pagano, Cinzia Girone, Francesco Borrelli, et al.Cell Reports. Medicine|August 31, 2024
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinibArturo Simoni-Nieves, Moshit Lindzen, Suvendu Giri, et al.Cancers|August 28, 2020
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase InhibitorDonatella Romaniello, Ilaria Marrocco, Nishanth Belugali Nataraj, et al.EMBO Molecular Medicine|December 8, 2017
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitorsMaicol Mancini, Hilah Gal, Nadège Gaborit, et al.Cell Reports|October 3, 2019
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing SarcomaSwati Srivastava, Nishanth Belugali Nataraj, Arunachalam Sekar, et al.Pageof 4